Pieris Pharmaceuticals (PIRS) Earnings Date, Estimates & Call Transcripts → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free PIRS Stock Alerts $11.72 +0.12 (+1.03%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 8EstimatedActual EPS (Mar. 29) -$4.00 Missed By -$4.00 Get Pieris Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for PIRS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenuePIRS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PIRS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. Pieris Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.17)($0.17)($0.17)Q2 20241($0.17)($0.17)($0.17)Q3 20241($0.19)($0.19)($0.19)Q4 20241($0.19)($0.19)($0.19)FY 20244($0.72)($0.72)($0.72)PIRS Earnings Date and InformationPieris Pharmaceuticals last posted its earnings results on March 29th, 2024. The biotechnology company reported ($4.00) earnings per share for the quarter. The business earned $1.30 million during the quarter. Pieris Pharmaceuticals has generated ($22.40) earnings per share over the last year (($22.40) diluted earnings per share). Pieris Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off prior year's report dates.Read More Pieris Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/8/2024Estimated)------- 3/29/2024Q4 2023-($4.00)($4.00)($0.06)-$1.30 million11/14/2023Q3 2023($8.80)($8.80)-($0.11)$7.74 million$19.52 million8/10/2023Q2 2023($12.80)$4.00+$16.80$0.05$3.76 million$20.06 million5/10/2023Q1 2023($11.20)($14.40)($3.20)($0.18)$6.51 million$1.94 million 3/29/2023Q4 2022($10.40)($8.80)+$1.60($0.11)$6.51 million$5.85 million11/2/2022Q3 2022($12.80)($10.40)+$2.40($0.13)$4.51 million$5.37 million Get the Latest News and Ratings for PIRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pieris Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($8.80)($11.20)($2.40)($0.14)$10.47 million$3.70 million5/11/2022Q1 2022($9.60)($5.60)+$4.00($0.07)$11.31 million$10.99 million 3/1/2022Q4 2021($24.00)($10.40)+$13.60($0.13)$4.91 million$8.44 million11/2/2021Q3 2021($19.20)($19.20)-($0.24)$7.98 million$4.06 million 8/4/2021Q2 2021($16.00)($20.00)($4.00)($0.25)$8.53 million$3.29 million 5/17/2021Q1 2021($13.60)($5.60)+$8.00($0.07)$6.47 million$15.63 million Pieris Pharmaceuticals Earnings - Frequently Asked Questions When is Pieris Pharmaceuticals's earnings date? Pieris Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 8th, 2024 based off last year's report dates. Learn more on PIRS's earnings history. How much revenue does Pieris Pharmaceuticals generate each year? Pieris Pharmaceuticals (NASDAQ:PIRS) has a recorded annual revenue of $42.81 million. How much profit does Pieris Pharmaceuticals generate each year? Pieris Pharmaceuticals (NASDAQ:PIRS) has a recorded net income of -$24.54 million. PIRS has generated -$22.40 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: AYTU Earnings Results AVTX Earnings Results ORGS Earnings Results NRBO Earnings Results TLPH Earnings Results NERV Earnings Results COCP Earnings Results VBIV Earnings Results KPRX Earnings Results GLTO Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:PIRS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pieris Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
